[The uvea and crystalline lens: toxicity of new medications].
The development of pharmaceutical industry brings us constantly new therapeutic agents. Whatever their delivery method, all these agents can potentially damage the ocular tissues. The WHO has established criteria to statue on the level of certainty between the drug and its adverse reaction. This article reviews the inflammatory lesions of the uvea and the lesions of the crystalline lens, which can be caused by the currently available medications. It develops the new pharmacologic agents and insists on the older ones sometimes already reported in the Bull. Soc. belge Ophtalmol in 1972, whose toxicity on the uvea or on the crystalline lens was then poorly known or rarely mentioned in the literature.
Lefebvre
P
P
Service d'Ophtalmologie, Hôpital Erasme, Université Libre de Bruxelles, Bruxelles. pierre.lefebvre@ulb.ac.be
D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007908:Lens, Crystalline / Q000187:drug effects*; D004364:Pharmaceutical Preparations / Q000008:administration & dosage; D014605:Uveitis / Q000139:chemically induced*; D014612:Vaccines / Q000008:administration & dosage / Q000009:adverse effects*
D004364:Pharmaceutical Preparations; D014612:Vaccines